HIV vaccine

On Wednesday, Inovio Pharmaceuticals Inc (NASDAQ: INO) announced the results of a study on its HIV vaccine, PENNVAX-GP, stating the drug “produced amongst the highest overall levels of immune response rates ever demonstrated in a human study by an HIV vaccine.” Benzinga was unable to...